Homocystinuria is a genetic disorder in which the body cannot break down a particular amino acid. The disorder passes from parents to children in an autosomal recessive manner, which means that two ...
Dublin, Dec. 18, 2024 (GLOBE NEWSWIRE) -- The "Homocystinuria - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering. This report provides comprehensive insights ...
Homocystinuria (HCY) is a rare condition that interferes with your body’s ability to break down a protein from the food you eat. Protein is made of smaller building blocks called amino acids. Normally ...
Direct-sequence analysis of PCR-amplified CBS cDNA was employed to identify sequence mutations in the CBS gene from 3 patients with pyridoxine-nonresponsive homocystinuria. These mutations are ...
This page lists all known medications that could potentially lead to 'Homocystinuria' as a side effect. It's important to note that mild side effects are quite common with medications. The ...
Homocystinuria is the most common inborn error of sulfur amino acid metabolism. It is most commonly caused by cystathionine beta-synthase (CBS) deficiency, which is ...
Dublin, June 14, 2022 (GLOBE NEWSWIRE) -- The "Homocystinuria - Market Insight, Epidemiology and Market Forecast -2032" report has been added to ResearchAndMarkets.com's offering. The report delivers ...
LEXINGTON, Mass.--(BUSINESS WIRE)--Orphan Technologies, a company dedicated to helping patients control their homocysteine levels, today announced that OT-58 for the treatment of cystathionine beta ...
Denovo Sciences Inc, a pioneer in AI-driven drug discovery based on synthetic data, Weill Cornell Medicine-Qatar (WCM-Q), and Sidra Medicine are engaging in a collaboration to identify and develop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback